Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06625216Recruiting

Severe Asthma Network Italy

Role: lead

NCT07175610Not Yet Recruiting

LUpus Eritematoso Sistemico NETwork and Registry

Role: lead

NCT06499480Recruiting

Italian Registry of Allergen ImmunoTherapy

Role: lead

NCT04796844Recruiting

MANI Real-life Perspective Observatory

Role: collaborator

All 4 trials loaded